PVI

Pura Vida Investments Portfolio holdings

AUM $16.6M
1-Year Return 3.82%
This Quarter Return
+3.9%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$328M
AUM Growth
+$41.7M
Cap. Flow
+$26.4M
Cap. Flow %
8.07%
Top 10 Hldgs %
45.79%
Holding
116
New
19
Increased
20
Reduced
14
Closed
21

Top Buys

1
SNN icon
Smith & Nephew
SNN
$10.9M
2
STAA icon
STAAR Surgical
STAA
$7.16M
3
REGN icon
Regeneron Pharmaceuticals
REGN
$6.26M
4
ZBH icon
Zimmer Biomet
ZBH
$5.89M
5
BRKR icon
Bruker
BRKR
$5M

Top Sells

1
XRAY icon
Dentsply Sirona
XRAY
$10.4M
2
AXGN icon
Axogen
AXGN
$6.79M
3
AXSM icon
Axsome Therapeutics
AXSM
$5.3M
4
CELG
Celgene Corp
CELG
$4.72M
5
GMED icon
Globus Medical
GMED
$3.95M

Sector Composition

1 Healthcare 89.84%
2 Industrials 2.49%
3 Consumer Staples 1.36%
4 Materials 0.27%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
KALA icon
51
KALA BIO
KALA
$102M
$1.91M 0.29%
5,978
– –
PSNL icon
52
Personalis
PSNL
$465M
$1.77M 0.27%
+65,000
New +$1.77M
ADPT icon
53
Adaptive Biotechnologies
ADPT
$1.96B
$1.69M 0.26%
+35,000
New +$1.69M
IART icon
54
Integra LifeSciences
IART
$1.25B
$1.4M 0.21%
+25,000
New +$1.4M
AMRS
55
DELISTED
Amyris Inc.
AMRS
$882K 0.13%
+247,668
New +$882K
TNDM icon
56
Tandem Diabetes Care
TNDM
$850M
$645K 0.1%
10,000
-30,000
-75% -$1.94M
APTO
57
DELISTED
Aptose Biosciences, Inc.
APTO
$392K 0.06%
+333
New +$392K
GRCE
58
Grace Therapeutics, Inc. Common Stock
GRCE
$44.3M
$380K 0.06%
6,940
+2,605
+60% +$143K
VTGN icon
59
VistaGen Therapeutics
VTGN
$109M
$308K 0.05%
14,167
– –
SYNH
60
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$255K 0.04%
+5,000
New +$255K
AXSM icon
61
Axsome Therapeutics
AXSM
$6.25B
$201K 0.03%
7,800
-205,845
-96% -$5.3M
ADMA icon
62
ADMA Biologics
ADMA
$4.03B
– –
0
– –
ALGN icon
63
Align Technology
ALGN
$10.1B
– –
0
– –
ARAY icon
64
Accuray
ARAY
$170M
– –
0
– –
AXGN icon
65
Axogen
AXGN
$735M
– –
-322,500
Closed -$6.79M
BDX icon
66
Becton Dickinson
BDX
$55.1B
– –
0
– –
BMY icon
67
Bristol-Myers Squibb
BMY
$96B
– –
0
– –
CPRX icon
68
Catalyst Pharmaceutical
CPRX
$2.48B
– –
-197,594
Closed -$1.01M
DVA icon
69
DaVita
DVA
$9.86B
– –
0
– –
EHC icon
70
Encompass Health
EHC
$12.6B
– –
0
– –
EHTH icon
71
eHealth
EHTH
$125M
– –
-30,000
Closed -$1.87M
EW icon
72
Edwards Lifesciences
EW
$47.5B
– –
0
– –
EXAS icon
73
Exact Sciences
EXAS
$10.2B
– –
0
– –
FXH icon
74
First Trust Health Care AlphaDEX Fund
FXH
$934M
– –
0
– –
GMED icon
75
Globus Medical
GMED
$8.18B
– –
-80,000
Closed -$3.95M
1 2
3
4 5